CHAMPIONS ONCOLOGY, INC. Net Income (Loss) Available to Common Stockholders, Diluted
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$1.18 million for the 12-month period ending 2026-04-30, per its 10-K filed 2026-07-27.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-07-27
- CHAMPIONS ONCOLOGY, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2026-04-30 was -$667.00K.
- CHAMPIONS ONCOLOGY, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2026-01-31 was -$279.00K, a 106.21% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-10-31 was $268.00K, a 63.19% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-07-31 was -$436.00K, a 133.21% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. net income (loss) available to common stockholders, diluted for fiscal 2026 was -$1.18M, a 124.99% decline from fiscal 2025.
- CHAMPIONS ONCOLOGY, INC. net income (loss) available to common stockholders, diluted for fiscal 2025 was $4.70M.
- CHAMPIONS ONCOLOGY, INC. net income (loss) available to common stockholders, diluted for fiscal 2024 was -$7.28M.
- CHAMPIONS ONCOLOGY, INC. net income (loss) available to common stockholders, diluted for fiscal 2023 was -$5.33M, a 1073.54% decline from fiscal 2022.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 12 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-04-30 | -$667.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27 | -$946.00K derived: sum of 2 quarters · filed 2026-07-27 | -$678.00K derived: sum of 3 quarters · filed 2026-07-27 | -$1.18M 10-K · filed 2026-07-27 | |||
| 2026-01-31 | -$279.00K 10-Q · filed 2026-03-12 | -$11.00K derived: sum of 2 quarters · filed 2026-03-12 | -$508.00K 10-Q · filed 2026-03-12 | -$2.28M derived: sum of 4 quarters · filed 2026-07-27 | |||
| 2025-10-31 | $268.00K 10-Q · filed 2025-12-15 | -$169.00K 10-Q · filed 2025-12-15 | -$2.00M derived: sum of 3 quarters · filed 2026-07-27 | $2.49M derived: sum of 4 quarters · filed 2026-07-27 | |||
| 2025-07-31 | -$436.00K 10-Q · filed 2025-09-15 | -$2.27M derived: sum of 2 quarters · filed 2026-07-27 | $2.22M derived: sum of 3 quarters · filed 2026-07-27 | $2.95M derived: sum of 4 quarters · filed 2026-07-27 | |||
| 2025-04-30 | -$1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27 | $2.66M derived: sum of 2 quarters · filed 2026-07-27 | $3.39M derived: sum of 3 quarters · filed 2026-07-27 | $4.70M 10-K · filed 2026-07-27 | |||
| 2025-01-31 | $4.50M 10-Q · filed 2026-03-12 | $5.22M derived: sum of 2 quarters · filed 2026-03-12 | $6.54M 10-Q · filed 2026-03-12 | $6.43M derived: sum of 4 quarters · filed 2026-03-12 | |||
| 2024-10-31 | $728.00K 10-Q · filed 2025-12-15 | $2.04M 10-Q · filed 2025-12-15 | $1.93M derived: sum of 3 quarters · filed 2025-12-15 | -$598.00K derived: sum of 4 quarters · filed 2025-12-15 | |||
| 2024-07-31 | $1.31M 10-Q · filed 2025-09-15 | $1.20M derived: sum of 2 quarters · filed 2025-09-15 | -$1.33M derived: sum of 3 quarters · filed 2025-09-15 | -$3.40M derived: sum of 4 quarters · filed 2025-09-15 | |||
| 2024-04-30 | -$109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-23 | -$2.64M derived: sum of 2 quarters · filed 2025-07-23 | -$4.71M derived: sum of 3 quarters · filed 2025-07-23 | -$7.28M 10-K · filed 2025-07-23 | |||
| 2024-01-31 | -$2.53M 10-Q · filed 2025-03-17 | -$4.60M derived: sum of 2 quarters · filed 2025-03-17 | -$7.17M 10-Q · filed 2025-03-17 | -$9.73M derived: sum of 4 quarters · filed 2025-03-17 | |||
| 2023-10-31 | -$2.07M 10-Q · filed 2024-12-16 | -$4.64M 10-Q · filed 2024-12-16 | -$7.20M derived: sum of 3 quarters · filed 2024-12-16 | -$9.64M derived: sum of 4 quarters · filed 2024-12-16 | |||
| 2023-07-31 | -$2.57M 10-Q · filed 2024-09-13 | -$5.13M derived: sum of 2 quarters · filed 2024-09-13 | -$7.57M derived: sum of 3 quarters · filed 2024-09-13 | ||||
| 2023-04-30 | -$2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-24 | -$5.00M derived: sum of 2 quarters · filed 2023-07-24 | -$5.33M 10-K · filed 2023-07-24 | ||||
| 2023-01-31 | -$2.44M 10-Q · filed 2023-03-16 | -$2.77M 10-Q · filed 2023-03-16 | |||||
| 2022-04-30 | -$344.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-24 | $443.00K derived: sum of 2 quarters · filed 2023-07-24 | $720.00K derived: sum of 3 quarters · filed 2023-07-24 | $548.00K 10-K · filed 2023-07-24 | |||
| 2022-01-31 | $787.00K 10-Q · filed 2023-03-16 | $1.06M derived: sum of 2 quarters · filed 2023-03-16 | $892.00K 10-Q · filed 2023-03-16 | $219.00K derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-10-31 | $277.00K 10-Q · filed 2021-12-13 | $105.00K 10-Q · filed 2021-12-13 | -$568.00K derived: sum of 3 quarters · filed 2022-07-22 | $391.00K derived: sum of 4 quarters · filed 2022-07-22 | |||
| 2021-07-31 | -$172.00K 10-Q · filed 2021-09-13 | -$845.00K derived: sum of 2 quarters · filed 2022-07-22 | $114.00K derived: sum of 3 quarters · filed 2022-07-22 | $115.00K derived: sum of 4 quarters · filed 2022-07-22 | |||
| 2021-04-30 | -$673.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | $286.00K derived: sum of 2 quarters · filed 2022-07-22 | $287.00K derived: sum of 3 quarters · filed 2022-07-22 | $362.00K 10-K · filed 2022-07-22 | |||
| 2021-01-31 | $959.00K 10-Q · filed 2022-03-15 | $740.00K 10-Q · filed 2021-03-15 | $960.00K derived: sum of 2 quarters · filed 2022-03-15 | $1.03M 10-Q · filed 2022-03-15 | $816.00K 10-Q · filed 2021-03-15 | -$1.13M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-10-31 | $1.00K 10-Q · filed 2021-12-13 | $76.00K 10-Q · filed 2021-12-13 | -$2.09M derived: sum of 3 quarters · filed 2021-12-13 | -$1.68M derived: sum of 4 quarters · filed 2021-12-13 | |||
| 2020-07-31 | $75.00K 10-Q · filed 2021-09-13 | -$2.09M derived: sum of 2 quarters · filed 2021-09-13 | -$1.68M derived: sum of 3 quarters · filed 2021-09-13 | -$1.38M derived: sum of 4 quarters · filed 2021-09-13 | |||
| 2020-04-30 | -$2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-26 | -$1.76M derived: sum of 2 quarters · filed 2021-07-26 | -$1.45M derived: sum of 3 quarters · filed 2021-07-26 | -$2.09M 10-K · filed 2021-07-26 | -$1.98M 10-K · filed 2020-07-28 | ||
| 2020-01-31 | $407.00K 10-Q · filed 2021-03-15 | $714.00K derived: sum of 2 quarters · filed 2021-03-15 | $72.00K 10-Q · filed 2021-03-15 | -$180.00K derived: sum of 4 quarters · filed 2021-03-15 | |||
| 2019-10-31 | $307.00K 10-Q · filed 2020-12-14 | -$334.00K 10-Q · filed 2020-12-14 | -$587.00K derived: sum of 3 quarters · filed 2020-12-14 | -$956.00K derived: sum of 4 quarters · filed 2020-12-14 | |||
| 2019-07-31 | -$641.00K 10-Q · filed 2020-09-14 | -$894.00K derived: sum of 2 quarters · filed 2020-09-14 | -$1.26M derived: sum of 3 quarters · filed 2020-09-14 | -$996.00K derived: sum of 4 quarters · filed 2020-09-14 | |||
| 2019-04-30 | -$253.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28 | -$622.00K derived: sum of 2 quarters · filed 2020-07-28 | -$355.00K derived: sum of 3 quarters · filed 2020-07-28 | $128.00K 10-K · filed 2020-07-28 | |||
| 2019-01-31 | -$369.00K 10-Q · filed 2020-03-16 | -$102.00K derived: sum of 2 quarters · filed 2020-03-16 | $381.00K 10-Q · filed 2020-03-16 | -$252.00K derived: sum of 4 quarters · filed 2020-03-16 | |||
| 2018-10-31 | $267.00K 10-Q · filed 2019-12-16 | $750.00K 10-Q · filed 2019-12-16 | $117.00K derived: sum of 3 quarters · filed 2019-12-16 | $41.00K derived: sum of 4 quarters · filed 2019-12-16 | |||
| 2018-07-31 | $482.00K 10-Q · filed 2019-09-16 | -$150.00K derived: sum of 2 quarters · filed 2019-09-16 | -$226.00K derived: sum of 3 quarters · filed 2019-09-16 | -$320.00K derived: sum of 4 quarters · filed 2019-09-16 | |||
| 2018-04-30 | -$632.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-29 | -$708.00K derived: sum of 2 quarters · filed 2019-07-29 | -$802.00K derived: sum of 3 quarters · filed 2019-07-29 | -$1.48M 10-K · filed 2019-07-29 | |||
| 2018-01-31 | -$76.00K 10-Q · filed 2019-03-18 | -$170.00K derived: sum of 2 quarters · filed 2019-03-18 | -$844.00K 10-Q · filed 2019-03-18 | ||||
| 2017-10-31 | -$94.00K 10-Q · filed 2018-12-17 | -$768.00K 10-Q · filed 2018-12-17 | |||||
| 2017-07-31 | -$674.00K 10-Q · filed 2018-09-14 | ||||||
| 2016-04-30 | -$2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | -$4.99M derived: sum of 2 quarters · filed 2016-07-29 | -$7.53M derived: sum of 3 quarters · filed 2016-07-29 | -$10.45M 10-K · filed 2016-07-29 | |||
| 2016-01-31 | -$2.41M 10-Q · filed 2016-03-16 | -$4.96M derived: sum of 2 quarters · filed 2016-03-16 | -$7.87M 10-Q · filed 2016-03-16 | -$11.13M derived: sum of 4 quarters · filed 2016-07-29 | |||
| 2015-10-31 | -$2.55M 10-Q · filed 2015-12-15 | -$5.46M 10-Q · filed 2015-12-15 | -$8.72M derived: sum of 3 quarters · filed 2016-07-29 | -$12.15M derived: sum of 4 quarters · filed 2016-07-29 | |||
| 2015-07-31 | -$2.91M 10-Q · filed 2015-09-11 | -$6.17M derived: sum of 2 quarters · filed 2016-07-29 | -$9.61M derived: sum of 3 quarters · filed 2016-07-29 | -$13.31M derived: sum of 4 quarters · filed 2016-07-29 | |||
| 2015-04-30 | -$3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | -$6.69M derived: sum of 2 quarters · filed 2016-07-29 | -$10.40M derived: sum of 3 quarters · filed 2016-07-29 | -$14.12M 10-K · filed 2016-07-29 | |||
| 2015-01-31 | -$3.44M 10-Q · filed 2016-03-16 | -$7.14M derived: sum of 2 quarters · filed 2016-03-16 | -$10.86M 10-Q · filed 2016-03-16 | -$13.12M derived: sum of 4 quarters · filed 2016-03-16 | |||
| 2014-10-31 | -$3.70M 10-Q · filed 2015-12-15 | -$7.46M 10-Q · filed 2015-12-15 | -$9.68M derived: sum of 3 quarters · filed 2015-12-15 | -$11.10M derived: sum of 4 quarters · filed 2015-12-15 | |||
| 2014-07-31 | -$3.70M 10-Q · filed 2015-09-11 | -$5.98M derived: sum of 2 quarters · filed 2015-09-11 | -$7.40M derived: sum of 3 quarters · filed 2015-09-11 | -$9.71M derived: sum of 4 quarters · filed 2015-09-11 | |||
| 2014-04-30 | -$2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | -$3.69M derived: sum of 2 quarters · filed 2015-07-29 | -$6.01M derived: sum of 3 quarters · filed 2015-07-29 | -$7.41M 10-K · filed 2015-07-29 | |||
| 2014-01-31 | -$1.42M 10-Q · filed 2015-03-17 | -$3.74M derived: sum of 2 quarters · filed 2015-03-17 | -$5.13M 10-Q · filed 2015-03-17 | ||||
| 2013-10-31 | -$2.32M 10-Q · filed 2014-12-15 | -$4.56M 10-Q · filed 2014-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |